Vertex Pharmaceuticals (VRTX) News Today $511.74 +8.54 (+1.70%) Closing price 04:00 PM EasternExtended Trading$513.11 +1.37 (+0.27%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Vanguard Group Inc. Acquires 98,654 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Vanguard Group Inc. raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,258,288 shares of the pharmaceuticMarch 24 at 7:07 AM | marketbeat.comStevens Capital Management LP Makes New $829,000 Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Stevens Capital Management LP acquired a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 2,058 shares of the pharmaceutical company'sMarch 24 at 6:41 AM | marketbeat.comSimplify Asset Management Inc. Acquires Shares of 4,689 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Simplify Asset Management Inc. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,689 shares of the pharmaceuticMarch 24 at 6:18 AM | marketbeat.comKLP Kapitalforvaltning AS Makes New $35.01 Million Investment in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)KLP Kapitalforvaltning AS purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 86,941 shares of the pharmaceutical company's stock,March 24 at 5:49 AM | marketbeat.comSei Investments Co. Acquires 61,234 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sei Investments Co. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 28.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 275,135 shares of the pharmaceutical compMarch 24 at 5:33 AM | marketbeat.comAmerican Century Companies Inc. Lowers Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)American Century Companies Inc. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 473,360 sharMarch 24 at 5:33 AM | marketbeat.comSummit Global Investments Sells 813 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Summit Global Investments decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,977 shares of the phMarch 24 at 5:09 AM | marketbeat.comWhittier Trust Co. Increases Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Whittier Trust Co. boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 33.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,045 shares of the pharmaceutical company's stock after purchasing an aMarch 24 at 4:50 AM | marketbeat.comJim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”March 23 at 12:34 PM | insidermonkey.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Vestor Capital LLCVestor Capital LLC lifted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2,589.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,736 shares of the pharmaceutical company'sMarch 23 at 6:24 AM | marketbeat.comMizuho Securities USA LLC Has $9.83 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Mizuho Securities USA LLC raised its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 45.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 24,408 shares of the pharmaceutical company's stock after purchasing an additioMarch 23 at 6:23 AM | marketbeat.comCyrus J. Lawrence LLC Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Cyrus J. Lawrence LLC cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 23.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,384 shares of the pharmaceutical company's stock after selling 6,313 sharesMarch 23 at 6:16 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Virtu Financial LLCVirtu Financial LLC lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 60.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,521 shares of the pharmaceutical coMarch 23 at 6:09 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Washington Trust BankWashington Trust Bank decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,811 shares of the pharmaceutical company's stock after seMarch 23 at 5:41 AM | marketbeat.comTD Private Client Wealth LLC Sells 7,470 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)TD Private Client Wealth LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 54.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,217 shares of the pharmaceuticalMarch 23 at 5:40 AM | marketbeat.comAxxcess Wealth Management LLC Has $424,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Axxcess Wealth Management LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 63.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,052 shares of the pharmaceutical coMarch 23 at 4:18 AM | marketbeat.comMadison Investment Advisors LLC Acquires New Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Madison Investment Advisors LLC acquired a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 14,522 shares of the pharmaceutical company's stock, valuedMarch 23 at 3:53 AM | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 1,428 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 54March 22 at 5:21 AM | marketbeat.comTeacher Retirement System of Texas Has $42.24 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Teacher Retirement System of Texas boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 26.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 104,895 shares of the pharmaceutical company's stock after acquiringMarch 22 at 5:11 AM | marketbeat.comSandy Spring Bank Has $1.92 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sandy Spring Bank lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 313.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,776 shares of the pharmaceutical compMarch 22 at 5:11 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Vinva Investment Management LtdVinva Investment Management Ltd grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 43.8% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,512 shares of the pharmaceutical company's stock after acquiring an additMarch 22 at 4:54 AM | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Acquires Shares of 1,233 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)OVERSEA CHINESE BANKING Corp Ltd bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,233 shares of theMarch 22 at 4:53 AM | marketbeat.comNorthwest & Ethical Investments L.P. Has $11.20 Million Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Northwest & Ethical Investments L.P. grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,822 shaMarch 21 at 6:53 AM | marketbeat.comBlueshift Asset Management LLC Acquires New Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Blueshift Asset Management LLC purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,729 shares of the pharmaceutical company's stock, valued at approxiMarch 21 at 6:44 AM | marketbeat.comMaryland State Retirement & Pension System Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Maryland State Retirement & Pension System reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,932 sharMarch 21 at 5:22 AM | marketbeat.comTrillium Asset Management LLC Sells 1,122 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Trillium Asset Management LLC decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,962 shares of the pharmaceutical company's stock afterMarch 21 at 5:21 AM | marketbeat.comThrivent Financial for Lutherans Lowers Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Thrivent Financial for Lutherans reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownedMarch 21 at 4:56 AM | marketbeat.comHarvest Fund Management Co. Ltd Boosts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Harvest Fund Management Co. Ltd raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 27.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,225 shares of the phaMarch 20, 2025 | marketbeat.comNasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does NextMarch 20, 2025 | msn.comA Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The PackMarch 19, 2025 | msn.comIs Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?March 19, 2025 | insidermonkey.comXponance Inc. Acquires 539 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Xponance Inc. boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,507 shares of the pharmaceutical compMarch 19, 2025 | marketbeat.comCautious Outlook on Vertex Pharmaceuticals’ Journavx Amid Market Penetration Challenges and Accessibility ConcernsMarch 19, 2025 | tipranks.com22,861 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Acquired by Generali Asset Management SPA SGRGenerali Asset Management SPA SGR bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 22,861 shares of the pharmaceuticMarch 19, 2025 | marketbeat.comAdvisors Asset Management Inc. Purchases 1,145 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Advisors Asset Management Inc. boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,61March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Acquires 983 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)William Blair Investment Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 77,532 shares of the pharmaceutical comMarch 19, 2025 | marketbeat.comEd Kaye, founding CEO of Stoke Therapeutics, steps downMarch 18, 2025 | bizjournals.comNikko Asset Management Americas Inc. Sells 1,092 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Nikko Asset Management Americas Inc. lowered its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 7,379 shares of the pharmaceutical company's stock after selling 1March 18, 2025 | marketbeat.comCibc World Markets Corp Buys 5,665 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Cibc World Markets Corp grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 13.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,339 shares of the pharmaceutical company's stock after purchasinMarch 18, 2025 | marketbeat.comCorient Private Wealth LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Corient Private Wealth LLC reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 12.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 113,146 shares of the pharmaceutical coMarch 18, 2025 | marketbeat.comEnvestnet Portfolio Solutions Inc. Sells 17,777 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Envestnet Portfolio Solutions Inc. cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 48.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,249 shares of the pharmaceutical compMarch 18, 2025 | marketbeat.com3 Unstoppable Stocks You Can Buy Now Without Any HesitationMarch 17, 2025 | fool.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Frank Rimerman Advisors LLCFrank Rimerman Advisors LLC reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 38.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,272 shares of the pharmaceuticaMarch 17, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Commonwealth Equity Services LLCCommonwealth Equity Services LLC raised its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 64,120 shares of the pharmaceutical company'sMarch 17, 2025 | marketbeat.comAlphaQuest LLC Has $208,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)AlphaQuest LLC cut its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 84.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 517 shares of the pharmaceutical companMarch 17, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) have received an average rating of "Moderate Buy" from the twenty-six brokerages that are currently covering the firm, Marketbeat Ratings reports. Ten analysts have rated the stock with a hold recommendation, fifteen haveMarch 17, 2025 | marketbeat.comNatixis Advisors LLC Boosts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Natixis Advisors LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 20.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 557,644 sharMarch 16, 2025 | marketbeat.comCopperwynd Financial LLC Purchases 576 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Copperwynd Financial LLC raised its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,556 shares of the pharmaceutical company's sMarch 16, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Holdings Cut by Avantax Advisory Services Inc.Avantax Advisory Services Inc. lowered its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 8.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,471 shares of the pharmaceutical coMarch 16, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $8.46 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 168.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional iMarch 16, 2025 | marketbeat.com Remove Ads Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.380.63▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼4123▲VRTX Articles Average Week Remove Ads Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Neurocrine Biosciences News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.